Is there a case for PAF antagonists in the treatment of ischemie states?

This publication has 23 references indexed in Scilit:

• Myocardial dysfunction and coronary vasoconstriction induced by platelet-activating factor in the post-infarcted rabbit isolated heart
  Journal of Molecular and Cellular Cardiology, 1988
• Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor.
  Journal of Clinical Investigation, 1988
• Leukotriene production in human neutrophils primed by recombinant human granulocyte/macrophage colony-stimulating factor and stimulated with the complement component C5A and FMLP as second signals.
  The Journal of Experimental Medicine, 1988
• Glomeruli from ischemic rat kidneys produce increased amounts of platelet activating factor
  Biochemical and Biophysical Research Communications, 1988
• Presence of specific binding sites for platelet-activating factor (PAF) in brain
  Biochemical and Biophysical Research Communications, 1988
• Effects of a platelet activating factor antagonist (BN 52021) on free fatty acids, diacylglycerols, polyphosphoinositides and blood flow in the gerbil brain: Inhibition of ischemia-reperfusion induced cerebral injury
  Biochemical and Biophysical Research Communications, 1987
• Platelet activating factor receptor blockade enhances recovery after multifocal brain ischemia
  Life Sciences, 1987
• Evidence for existence of various homologues and analogues of platelet activating factor in a lipid extract of bovine brain
  Biochemical and Biophysical Research Communications, 1987
• Inhibition of human lymphocyte proliferation and interleukin 2 production by platelet activating factor (PAF-acether]: Reversal by a specific antagonist, BN 52021
  Biochemical and Biophysical Research Communications, 1987
• PAF-acether specific binding sites: 2. Design of specific antagonists
  Trends in Pharmacological Sciences, 1986